Papers
7
Total Citations
47
H-Index
4
About
Chung-Yi Liu is a leading urologic surgeon and researcher specializing in robotic-assisted minimally invasive surgery for renal and prostate cancers. His work focuses on advancing nephron-sparing techniques and improving functional outcomes after robotic procedures. Liu’s most impactful contribution is demonstrating the clinical benefits of indocyanine green (ICG) fluorescence during robot-assisted partial nephrectomy (RAPN), a study with 18 citations that showed superior intraoperative and postoperative outcomes for both benign and malignant renal tumors. He has also pioneered robot-assisted laparoendoscopic single-site adrenalectomy (14 citations), advancing cosmetic and recovery benefits. In prostate cancer, Liu developed predictive models for biochemical failure after positive surgical margins and a simplified nomogram integrating clinical and imaging parameters to forecast early urinary incontinence recovery after robotic prostatectomy. His recent work on predicting hemorrhagic complications in RAPN for angiomyolipoma and renal tumors has further refined risk assessment, using tumor diameter and depth as simple, reliable predictors. With over 47 citations across his most-cited papers, Liu’s research is shaping safer, more effective robotic urologic surgery and personalized postoperative care.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robot-assisted laparoendoscopic single site adrenalectomy14 citations · 2017
- 3
- 4
- 5
- 6
- 7